- AutorIn
- Jakob Mitgau
- Titel
- Characterization of the mechanical forces required to activate the adhesion G protein-coupled receptor ADGRG6/GPR126 through N-terminal ligands
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-1073118
- Datum der Einreichung
- 23.07.2024
- Datum der Verteidigung
- 26.06.2025
- Abstract (EN)
- Despite Adhesion G protein-coupled receptors (aGPCRs) representing the second largest family of G protein-coupled receptors (GPCRs), our understanding of their relevance in physiology and pathophysiology has only started growing in recent years and is currently expanding faster than ever. To utilize this knowledge in the future for potential therapeutic approaches, it is vital to deorphanize the receptors and precisely understand the mechanisms underlying aGPCR activation. Among the family of aGPCRs, ADGRG6/GPR126 is one of the more comprehensively studied receptors. It is known to be important for myelination in the peripheral nervous system as well as the development of the placenta and the inner ear. ADGRG6 is associated with adolescent idiopathic scoliosis and has been shown to promote breast cancer development and regulate colorectal cancer. Several ligands of ADGRG6 are known, including small molecules like apomorphine and progesterone, as well as several extracellular matrix (ECM) proteins such as collagen IV and laminin 211. The receptor also has been shown to be activatable by mechanical forces alone or the combination of mechanical forces and ECM ligand (laminin 211). This implies a potential complex interplay between the receptor’s ligands and mechanical forces that modulates receptor activity and translates the ligand-receptor interaction within the receptor’s N-terminal fragment (NTF) into intracellular signalling. Just prior to my thesis studies, Julius Franke demonstrated that an antibody targeting an introduced Hemagglutinin-Tag (HA-Tag) at the amino terminus (N terminus) of ADGRG6 can activate the receptor as well. The question that arises is, what could be the underlying mechanism of antibody-mediated activation of ADGRG6? Considering not just the antibody-mediated receptor activation itself, but also the possibility of further increasing receptor signalling via the addition of a secondary antibody, two different models could explain this pattern: On the one hand, activation might occur due to cross-linking of the receptor via the antibody and on the other hand the activation might happen due to the “weight” of the antibody. In this model, mechanical forces pulling on the NTF or pushing down on the receptor might be affecting the receptor. To evaluate the two different models, it was tested whether the receptor is activatable by the anti-HA antibody's Fragment antigen binding region (Fab fragment) alone. As the Fab fragment only binds to one receptor at a time instead of two, it does not allow for cross-linking between receptors. Independent of the Fab fragment concentration used, no activation of ADGRG6 was observed. This supports a cross-linking activation model. In order to characterize potential mechanical forces mediated by the antibody, a setup combining Atomic Force Microscopy (AFM) with a fluorescent cyclic adenosine monophosphate (cAMP) sensor was established. Antibody-coated tips were utilized to apply both pushing and pulling forces to ADGRG6 on the surface of single living cells. The fluorescent cAMP sensor, pink Flamindo, was used to monitor changes in intracellular cAMP concentrations in real-time. Different time intervals (30-300 seconds) and force levels (0.25 nN to 1.5 nN) were applied to establish an ideal testing paradigm. For each setup, the fluorescence intensity of the cAMP sensor was compared right before and right after mechanical stimulation. Detectable activation of ADGRG6 was observed under both pulling and pushing forces at the lowest applied strength. Increasing the applied forces did not result in higher cAMP production. This indicates an antibody-mediated activation already occurring upon contact with the receptor. The activation does not require any further mechanical stimulation, at least within the measurable range of the used setup. Therefore, a model of receptor activation through cross-linking likely provides the mechanistic explanation for receptor activation by the antibody. A G Protein-coupled receptor proteolysis site (GPS)-cleavage deficient mutant of the receptor was irresponsive to the antibody interaction, despite the confirmed binding between antibody andreceptor through an Enzyme-linked immunosorbent assay (ELISA). Thus, this mutant could be used as a negative control for pulling assays. After a reliable tool to transfer force through an interacting molecule onto the receptor and monitor subsequently occurring changes in cAMP levels was established, two known ECM ligands of ADGRG6, collagen IV and laminin 211 were tested towards their requirements for additional force application in order to induce receptor activation. Both ligands were tested in a pushing and in a pulling setup. Interestingly, collagen IV induced a significant increase in cAMP levels only when subjected to pushing forces of 1 nN, whilst lower or higher pushing or pulling forces were not able to activate the receptor. In contrast, while laminin 211 did not activate the receptor in combination with pushing forces, pulling forces of 0.75 nN induced cAMP production. These seemingly opposing findings align with the known physiological roles of these ligands within the context of basement membrane formation during the process of myelination: Laminin 211 is secreted among the first molecules and polymerizes to form a first leaky basement membrane. It was already suggested previously that this polymerization is the functional representation of mechano-activation. Collagen IV is subsequently secreted and forms the top layer of the basement membrane, which can be interpreted as exerting a pushing force onto ADGRG6. These opposing mechanisms of two ligands acting on the same receptor exemplify how different ECM molecules can have different influences on an aGPCR.It is important to note that there are several limitations to the approach. Although it enables work on a single-cell level, the cantilevers used are not suitable and the readout is not sensitive enough to investigate single-molecule interactions between antibodies/ligands and a receptor. Therefore, the specific forces identified to activate ADGRG6 on a whole-cell level do not enable the deduction of the forces required to activate an individual receptor.
- Freie Schlagwörter (EN)
- Adhesion GPCR, GPR126, ADGRG6, Mechano-activation, Atomic Force Microscopy
- Klassifikation (DDC)
- 610
- Den akademischen Grad verleihende / prüfende Institution
- Universität Leipzig, Leipzig
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:15-qucosa2-1073118
- Veröffentlichungsdatum Qucosa
- 09.10.2026
- Dokumenttyp
- Dissertation
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis
CC BY-NC 4.0- Inhaltsverzeichnis
LIST OF ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 G protein-coupled receptors (GPCRs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Adhesion G protein-coupled receptors (aGPCRs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 ADGRG6/GPR126 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Atomic force microscopy as a tool to study the characteristics of mechano-receptors . . . . 11 AIM OF THE THESIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 PUBLICATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Publication Manuscript . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Supplementary Material . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 REFFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 APPENDIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Personal Contribution to the Publication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 Erklärung über die eigenständige Abfassung der Arbeit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 Curriculum Vitae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 Publications and Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49